Destroy Lethal Bacteria News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cipla Doubles Remdesivir Production In India For Unprecedented Demand
The COVID-19 pandemic brought the world to its knees with its sheer virulence and adaptive ability. It forced the scientific community to work at an unprecedented pace to develop therapeutic regimens and vaccines to combat it. As researchers turned to existing drugs with the hopes of tackling the SARS-CoV-2 virus, one drug emerged as a viable candidate Remdesivir. Now, the drug manufactured by the US-based pharmaceutical company, Gilead Sciences, is being turned to as a savior.
Reports emerging from across India have stated that there is an acute shortage of Remdesivir, and sky-rocketing prices; highlighting not just the demand for the drug, but also the faith in it as the second wave sweeps the country. Let us take a look at Remdesivir s journey in the fight against COVID-19 ....

Democratic Republic Of The Congo , United States , United Kingdom , Nicholas Matheson , Peter Chin Hong , Cambridge University , University Of California , Gilead Sciences , Drug Administration , Central Drugs Standard Control Organisation , San Fransisco , Novel Coronavirus , Middle East , Democratic Republic , Apollo Hospital , Bharat Biotech , Australian Scientists Develop Nanotech , Destroy Lethal Bacteria , Cannabis Can Impair Vision , Warn Scientists , Remdesivir Coronavirus , Remdesivir To Treat Coronavirus , How Does Remdesivir Help In Treating Covid 19 , How Remdesivir Helps In Treating Covid 19 , Remdesivir Covid 19 , Remdesivir India ,